Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TWISTER: 2 Weeks LMWH for Distal DVT
NCT01252420Phase 4Unknown
- Sponsor
- Monash Medical Centre
- Start
- Nov 2010
- Primary completion
- Nov 2013
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 2
01
Overview
Phase 4, open-label, single-arm trial of enoxaparin in distal deep vein thrombosis, sponsored by Monash Medical Centre. Primary endpoint: Symptomatic recurrence of venous thrombosis (DVT, non fatal and fatal pulmonary embolism) at 3 months. Status: unknown.
02
Drugs
enoxaparin
03
Conditions
distal deep vein thrombosis
Beyond the preview
Go deeper on NCT01252420.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01252420.